Disclosure of elevated amyloid status is not associated with long-term suicidality in a preclinical AD trial. uri icon

authors

  • Grill, Joshua D
  • Aisen, Paul
  • Holdridge, Karen Chilcott
  • Mancini, Michele
  • Sperling, Reisa
  • Sultzer, David
  • Raman, Rema
  • Flournoy, Charlene
  • Ernstrom, Karin
  • Pierce, Aimee
  • Smith, Amanda
  • Rosenberg, Paul
  • Burns, Jeffrey
  • Karlawish, Jason

publication date

  • February 2025